Lipocine Inc (LPCN)
4.68
-0.02
(-0.43%)
USD |
NASDAQ |
May 03, 16:00
4.60
-0.08
(-1.71%)
After-Hours: 20:00
Lipocine Total Assets (Quarterly): 23.00M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 23.00M |
| September 30, 2023 | 24.75M |
| June 30, 2023 | 30.48M |
| March 31, 2023 | 34.02M |
| December 31, 2022 | 37.54M |
| September 30, 2022 | 39.42M |
| June 30, 2022 | 42.19M |
| March 31, 2022 | 47.60M |
| December 31, 2021 | 52.48M |
| September 30, 2021 | 40.39M |
| June 30, 2021 | 47.18M |
| March 31, 2021 | 50.58M |
| December 31, 2020 | 25.35M |
| September 30, 2020 | 24.75M |
| June 30, 2020 | 23.49M |
| March 31, 2020 | 20.99M |
| December 31, 2019 | 19.66M |
| September 30, 2019 | 17.34M |
| June 30, 2019 | 19.68M |
| March 31, 2019 | 22.99M |
| December 31, 2018 | 20.85M |
| September 30, 2018 | 22.69M |
| June 30, 2018 | 25.30M |
| March 31, 2018 | 31.68M |
| Date | Value |
|---|---|
| December 31, 2017 | 25.33M |
| September 30, 2017 | 26.26M |
| June 30, 2017 | 28.05M |
| March 31, 2017 | 27.22M |
| December 31, 2016 | 27.34M |
| September 30, 2016 | 29.55M |
| June 30, 2016 | 33.35M |
| March 31, 2016 | 38.77M |
| December 31, 2015 | 45.38M |
| September 30, 2015 | 48.43M |
| June 30, 2015 | 53.80M |
| March 31, 2015 | 25.06M |
| December 31, 2014 | 27.99M |
| September 30, 2014 | 32.02M |
| June 30, 2014 | 35.49M |
| March 31, 2014 | 42.10M |
| December 31, 2013 | 46.11M |
| September 30, 2013 | 37.17M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.0005M |
| December 31, 2012 | 0.0006M |
| September 30, 2012 | 0.0006M |
| June 30, 2012 | 0.0034M |
| March 31, 2012 | 0.0274M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
17.34M
Minimum
Sep 2019
52.48M
Maximum
Dec 2021
32.68M
Average
30.48M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Alpine Immune Sciences Inc | 379.85M |
| Eliem Therapeutics Inc | 110.47M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.632M |
| Shareholders Equity (Quarterly) | 20.37M |
| Current Ratio | 8.687 |